Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v8-EN
Language English English
Date Updated 2022-09-01 2022-08-15
Drug Identification Number 02257963 02257963
Brand name CLARUS CLARUS
Common or Proper name ISOTRETINOIN ISOTRETINOIN
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients ISOTRETINOIN ISOTRETINOIN
Strength(s) 40MG 40MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30BL 30BL
ATC code D10BA D10BA
ATC description ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-07-20 2022-07-20
Actual start date 2022-07-25 2022-07-25
Estimated end date 2022-09-06 2022-09-06
Actual end date 2022-08-29
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments